(BMY) Bristol-Myers Squibb - Performance 20.2% in 12m
Compare BMY with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
29.37%
#49 in Group
Rel. Strength 12m
77.54%
#1760 in Universe
Total Return 12m
20.21%
#44 in Group
Total Return 5y
41.26%
#61 in Group
12m Total Return: BMY (20.2%) vs XLV (-0.2%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group (based on Performance, Valuations and Relative Strength)
| Symbol | 1m | 12m | 5y | P/E | P/B | Growth Rating |
|---|---|---|---|---|---|---|
| CPH TO Cipher Pharmaceuticals |
-10.0% | 64.3% | 2,190% | 12.88 | 1.97 | 90.78 |
| PBH NYSE Prestige Brand Holdings |
-3.33% | 10.3% | 174% | 20.90 | 2.41 | 88.57 |
| NVS NYSE Novartis |
4.95% | 14.2% | 93.1% | 19.67 | 5.18 | 68.05 |
| NOVN SW Novartis |
2.68% | 15.2% | 77.9% | 19.33 | 5.01 | 65.13 |
| SUPN NASDAQ Supernus Pharmaceuticals |
-21.2% | -10.1% | 107% | 24.33 | 1.73 | 61.02 |
Performance Duell BMY vs XLV
| Total Return (including Dividends) | BMY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 7.70% | -1.75% | -9.56% |
| 3 Months | 9.26% | 2.48% | -8.43% |
| 12 Months | 20.21% | -0.24% | 8.24% |
| 5 Years | 41.26% | 90.57% | 147.98% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #25 | 9.62% | 19.1% |
| 3 Month | #48 | 6.62% | 19.3% |
| 12 Month | #43 | 20.5% | 11.1% |
| 5 Years | #63 | -25.9% | -43.0% |
| Trend Score (consistency of price movement) | BMY | XLV | S&P 500 |
| 1 Month | 90.1% | 24.5% | -95.3% |
| 3 Months | 48.9% | 82.3% | -17.6% |
| 12 Months | 80.2% | 23.5% | 91.5% |
| 5 Years | -4.1% | 90.5% | 84.5% |
FAQs
Does BMY Bristol-Myers Squibb outperforms the market?
Yes,
over the last 12 months BMY made 20.21%, while its related Sector, the Health Care Sector SPDR (XLV) made -0.24%.
Over the last 3 months BMY made 9.26%, while XLV made 2.48%.
Over the last 3 months BMY made 9.26%, while XLV made 2.48%.
Performance Comparison BMY vs Indeces and Sectors
BMY vs. Indices BMY is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.89% | 17.3% | 26.7% | 12.0% |
| US NASDAQ 100 | QQQ | 4.24% | 20.3% | 26.6% | 13.2% |
| US Dow Jones Industrial 30 | DIA | 4.19% | 16.2% | 26.1% | 14.0% |
| German DAX 40 | DAX | 3.56% | 7.97% | 4.94% | -4.61% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.31% | 6.65% | 4.19% | 9.51% |
| Hongkong Hang Seng | HSI | 1.10% | -0.26% | 9.25% | 7.71% |
| India NIFTY 50 | INDA | 1.05% | 11.4% | 41.0% | 23.3% |
| Brasil Bovespa | EWZ | -0.77% | 10.3% | 37.9% | 38.2% |
BMY vs. Sectors BMY is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 5.0% | 17.1% | 15.7% | 0.77% |
| Consumer Discretionary | XLY | 6.70% | 22.9% | 25.0% | 12.9% |
| Consumer Staples | XLP | 4.12% | 10.3% | 29.7% | 13.1% |
| Energy | XLE | -1.25% | 10.5% | 21.9% | 20.5% |
| Financial | XLF | 4.14% | 16.0% | 18.1% | 3.19% |
| Health Care | XLV | 3.81% | 9.45% | 32.6% | 20.5% |
| Industrial | XLI | 3.12% | 14.3% | 26.0% | 13.6% |
| Materials | XLB | 3.26% | 13.6% | 33.0% | 25.5% |
| Real Estate | XLRE | 3.89% | 11.4% | 33.9% | 14.0% |
| Technology | XLK | 3.77% | 20.9% | 30.9% | 20.1% |
| Utilities | XLU | -1.78% | 10.3% | 25.5% | -4.74% |
| Aerospace & Defense | XAR | 1.43% | 14.4% | 21.2% | 5.10% |
| Biotech | XBI | 1.42% | 13.0% | 40.5% | 31.6% |
| Homebuilder | XHB | 6.03% | 17.6% | 45.3% | 30.3% |
| Retail | XRT | 6.27% | 23.9% | 36.5% | 31.1% |